For those working in AI bio,
I just published an initial artifact of all the assays that are available today, and which CROs offer them.
https://t.co/zssH9HuF7H
Let me know what you think/anything I might be missing!
I am excited to share my lab's latest work online today @MolecularCell where we investigate the relationship between condensate formation and transcriptional activity of the cell-type specific coactivator MYOCD. https://t.co/Yo9zKHbGxg
@zachweinberg@jacobkimmel FDA review voucher type incentive program? SBIR or ARPA-H mechanisms to incentive the early academic lab to pre-clinical POC in animals?
Unironically, it is so good that biology is cool now. Everyone should be rooting for AI to cure all disease. Stop speculating about whether it will or will not happen and ask yourself what you personally can do to make it happen. Then do it
There’s enormous investment right now in predictive models of biology. Most of them learn from a single layer of the biological hierarchy, usually RNA, and assume what they find there carries over. Whether this large bet pays off depends on getting that mapping right. 🧵 [1/11]
Bryant et al. made adaptamers, <120 bp RNAs which act as regulatory elements for mRNAs so that translation only occurs in the presence of a small molecule inducer (tetracycline or doxycycline). A very clever design with lots of promise for gene therapy! https://t.co/pKra8blgEh
Glad to see this work from my postdoc published in @MolecularCell! 🧬🔬
We show how excessive PAR accumulation competes with RNA for RNA-binding proteins, impairing RNA export and reducing protein synthesis.
Expanding our understanding of PARP1 biology! 🧩
https://t.co/WdXtZExlHz
At the risk of a confusing positive-double-negative, I’m so aligned with @SimonDBarnett.
It appears Vertex hasn’t even made it to the starting line in the AI race. Their chairman seems to believe that because they ran AI “through a dataset of 10,000 compounds” and didn’t get a medicine out the other side, it means AI doesn’t work.
There are many dozens of AI-discovered drugs in the clinic - some in or approaching phase 3. Up from zero roughly 10 years ago. The first will get approved, then ten, then hundreds. That’s what exponential curves look like.
There can be plenty of debate around when we will hit 100 AI medicines approved, and it’s easy to be off by years (I originally thought we’d be there around now), but believing today that it isn’t going to happen in the coming years is the equivalent of being an ostrich with its head underground as the lions arrive.
Now that vaults are having another twitter moment, huge shoutout to Nancy Kedersha who co-discovered vaults and stress granules and did cool shit for a long time, all without having an independent laboratory.